United States · FDA National Drug Code directory

NEOSTIGMINE METHYLSULFATE

Source ingredient · 55 source records

Names are grouped within this source and country. A shared ingredient does not establish interchangeable medicines.

United States · Source reference 65145-111_de2f2948-6e31-43d4-9c59-816ec936f5f2

Neostigmine Methylsulfate

INJECTION / Caplin Steriles Limited

United States · Source reference 65145-112_de2f2948-6e31-43d4-9c59-816ec936f5f2

Neostigmine Methylsulfate

INJECTION / Caplin Steriles Limited

United States · Source reference 65219-811_0831f9a8-b6ff-4b49-91ad-8177f968f543

Neostigmine Methylsulfate

INJECTION, SOLUTION / Fresenius Kabi USA, LLC

United States · Source reference 70069-805_ea767851-b0ab-4a4c-a4b2-680ff4086636

Neostigmine Methylsulfate

INJECTION / Somerset Therapeutics, LLC

United States · Source reference 70069-806_ea767851-b0ab-4a4c-a4b2-680ff4086636

Neostigmine Methylsulfate

INJECTION / Somerset Therapeutics, LLC

United States · Source reference 70594-069_74ccc6d9-bde5-4c06-b40f-7980c5d5ca90

Neostigmine Methylsulfate

INJECTION / Xellia Pharmaceuticals USA LLC

United States · Source reference 70594-072_74ccc6d9-bde5-4c06-b40f-7980c5d5ca90

Neostigmine Methylsulfate

INJECTION / Xellia Pharmaceuticals USA LLC

United States · Source reference 71872-7271_facbe17e-4696-d5fe-e053-6394a90a8abe

Neostigmine Methylsulfate

INJECTION / Medical Purchasing Solutions, LLC

United States · Source reference 72572-462_6d9cef39-e95e-4dc7-96be-59dfb0bfa561

Neostigmine Methylsulfate

INJECTION / Civica, Inc.

United States · Source reference 76045-214_27e94d4f-f8d8-437a-a770-7020a9f8f61d

Neostigmine Methylsulfate

INJECTION, SOLUTION / Fresenius Kabi USA, LLC

United States · Source reference 76045-383_27e94d4f-f8d8-437a-a770-7020a9f8f61d

Neostigmine Methylsulfate

INJECTION, SOLUTION / Fresenius Kabi USA, LLC

United States · Source reference 68083-383_248b2834-6520-42e5-85cd-92c29eb7b804

Neostigmine methylsulfate

INJECTION / Gland Pharma Limited

United States · Source reference 68083-384_248b2834-6520-42e5-85cd-92c29eb7b804

Neostigmine methylsulfate

INJECTION / Gland Pharma Limited

United States · Source reference 70121-1478_52f5f95d-6168-497d-bbb7-74889d1b2733

Neostigmine methylsulfate

INJECTION / Amneal Pharmaceuticals LLC

United States · Source reference 70121-1479_52f5f95d-6168-497d-bbb7-74889d1b2733

Neostigmine methylsulfate

INJECTION / Amneal Pharmaceuticals LLC

United States · Source reference 70700-171_8649cf31-5ecf-2048-5bf0-1b6e84f190f4

Neostigmine methylsulfate

INJECTION / Xiromed LLC

United States · Source reference 70700-172_8649cf31-5ecf-2048-5bf0-1b6e84f190f4

Neostigmine methylsulfate

INJECTION / Xiromed LLC

United States · Source reference 71839-105_a90a9fa9-dc93-4e87-94fa-e578918ccfce

Neostigmine methylsulfate

INJECTION / BE Pharmaceuticals Inc.

United States · Source reference 71839-106_a90a9fa9-dc93-4e87-94fa-e578918ccfce

Neostigmine methylsulfate

INJECTION / BE Pharmaceuticals Inc.

United States · Source reference 84549-172_3a388c6f-cd8b-50c0-e063-6294a90a4316

Neostigmine methylsulfate

INJECTION / ProPharma Distribution

United States · Source reference 42023-269_a1b07822-805f-4c68-914f-1db1cead480a

PREVDUO

INJECTION / Endo USA

United States · Source reference 31722-994_8265ddeb-9723-49af-85fa-0699c4c3c6d7

neostigmine methylsulfate

INJECTION / Camber Pharmaceuticals Inc.

United States · Source reference 31722-995_8265ddeb-9723-49af-85fa-0699c4c3c6d7

neostigmine methylsulfate

INJECTION / Camber Pharmaceuticals Inc.

United States · Source reference 71288-500_bf415978-8e01-4c77-e053-2995a90a9ea3

neostigmine methylsulfate

INJECTION / Meitheal Pharmaceuticals Inc.

United States · Source reference 71288-501_bf415978-8e01-4c77-e053-2995a90a9ea3

neostigmine methylsulfate

INJECTION / Meitheal Pharmaceuticals Inc.

Browse ingredients in United States →